Mumbai: Drug and medical-devices maker Abbott has introduced its drug-eluting absorbable stent — bioresorbable vascular scaffold (BVS) — in India. According to the company, BVS dissolves into the body in about two-three years.
According to Amit Kumar, regional director for South and South-East Asia, Abbott, the device is made of polylactide, a naturally dissolvable material used in medical implants such as dissolving sutures.
The product was launched in India after clinical trials on 100 patients. The India launch follows within months after launch in Europe in October. The product is yet to be launched in the United States that has a stringent regulatory process.
BVS is estimated to cost the patient between Rs 2-3 lakh, per stent, as compared to a metallic DES (drug-eluting stent) that costs between Rs 70,000 and Rs 1 lakh. A stent is a thin wire mesh used to remove blocks in blood vessels. [Source: Hindu Business Line]